Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer.

Lee YJ, Shin KJ, Chae YC. · 2024

Read Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. by Lee YJ, Shin KJ, Chae YC. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc11059157.txt.

Introduction

Lee, Shin, and Chae review how cells choose what to pack into tiny export sacs in this 2024 paper. Exosomes are small sacs cells release to send proteins, fats, and gene messages to other cells. Their cargo decides where they act and what they do on arrival. How cells sort chosen cargo into the sacs is still not fully known.

The review gathers current insight on the sorting machinery for each cargo type. Membrane proteins, lipids, nucleic acids, and signal molecules each follow distinct loading rules. The resulting sac contents shape cell growth, immune action, and disease spread. Cancer gets particular emphasis, since tumours use these sacs to aid growth. The authors argue that mastering cargo choice is essential for using sacs as disease markers and drug carriers.

Catalog record

CREATORLee YJ, Shin KJ, Chae YC.
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11059157

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer By Yu Jin Lee, Kyeong Jin Shin, Young Chan Chae Published in: Experimental & Molecular Medicine DOI: 10.1038/s12276-024-01209-y ABSTRACT Abstract Extracellular vesicles (EVs), including exosomes, are increasingly recognized as potent mediators of intercellular communication due to their capacity to transport a diverse array of bioactive molecules. They assume vital roles in a wide range of physiological and pathological processes and hold significant promise as emerging disease biomarkers, therapeutic agents, and carriers for drug delivery. Exosomes encompass specific groups of membrane proteins, lipids, nucleic acids, cytosolic proteins, and other signaling molecules within their interior. These cargo molecules dictate targeting specificity and functional roles upon reaching recipient cells. Despite our growing understanding of the significance of exosomes in diverse biological processes, the molecular mechanisms governing the selective sorting and packaging of cargo within exosomes have not been fully elucidated. In this review, we summarize current insights into the molecular mechanisms that regulate the sorting of various molecules into exosomes, the resulting biological functions, and potential clinical applications, with a particular emphasis on their relevance in cancer and other diseases. A comprehensive understanding of the loading processes and mechanisms involved in exosome cargo sorting is essential for uncovering the physiological and pathological roles of exosomes, identifying therapeutic targets, and advancing the clinical development of exosome-based therapeutics. Subject terms: Cell signalling, Cancer microenvironment INTRODUCTION Overview of extracellular vesicles (EVs) EVs represent a diverse class of cell-derived membranous structures that play pivotal roles in regulating intercellular communication. These vesicles are involved in transmitting bioactive molecules and modulating various physiological and pathological processes. There are several subtypes of EVs, including exosomes, which were first characterized through electron microscopy. Initially, these EVs were considered waste bags responsible for expelling unwanted cellular products outside of the cell. Notably, transferrin was the first cargo discovered within these EVs1. However, beginning in the early 2000s, the advent of advanced analytical methods, such as mass spectrometry and next-generation sequencing, revealed that EVs contain a diverse array of biomolecules, including proteins, lipids, metabolites, and nucleic acids, including various types of DNA and RNA2,3. This revelation reshaped our understanding of exosomes and highlighted the significance of EVs in intercellular communication beyond mere cellular waste removal. Furthermore, research on EVs has rapidly expanded as their potential for diagnostic and therapeutic applications in various diseases, including neurodegenerative disorders, cardiovascular dysfunction, metabolic diseases, and immune-related conditions, including cancer, became evident4. EVs are secreted into the extracellular space and taken up by target cells, thereby modulating their phenotype. In contrast to the conventional ligand‒receptor-mediated communication system, EV-mediated signaling involves the direct transfer of diverse cargo into recipient cells, thereby enabling the direct regulation of cellular functions at multiple levels, including the genetic, signaling pathway, and functional levels. As innate vesicles, exosomes shield their cargo from enzymatic degradation and exhibit reduced immunogenicity within the circulatory system, making them ideal for transporting biomaterials5,6. Due to their efficacy in delivering biomaterials, EVs are highly promising candidates for a wide array of biomedical applications, including drug delivery, diagnostics, and therapeutic interventions4. Exosome biogenesis is a complex, highly regulated process that involves several sequential stages, from the initial formation of early endosomes to the eventual release of fully mature exosomes into the extracellular environment. Among these stages, the selective sorting of cargo molecules into nascent exosome vesicles has emerged as a critical determinant of exosome functionality, diversity, and specificity7. In this comprehensive review, we aim to provide an in-depth overview of our current understanding of the cargo sorting mechanisms involved in exosome biogenesis. We explore the various classes of molecules that constitute exosome cargo, the regulatory factors and machinery that govern cargo selection and packaging, and the implications of cargo sorting in disease contexts. Understanding how exosomes manage cargo sorting is a crucial objective for disease management and a foundational step in advancing sophisticated exosome-based therapies7,8. This approach facilitates the design of exosomes that are better equipped to transport therapeutic payloads to specific cells or tissues, thereby enhancing the efficacy and precision of EV treatments in clinical applications. Classification of EVs EVs are primarily classified into three major groups based on their size and cellular origin, although EV classification is continuously evolving7. Within this classification, exosomes constitute the smallest EVs, typically measuring between 30 and 150 nm in diameter9. They originate from the endocytic pathway, specifically from late endosomes known as multivesicular bodies (MVBs), where exosome formation begins. Subsequent fusion of MVBs with the plasma membrane releases their internal vesicles into the extracellular space, resulting in exosomes10,11. Exosomes can encapsulate a wide array of bioactive molecules, including microRNAs (miRNAs), proteins, and lipids. The composition of exosomal cargo is subject to regulation by various signaling pathways and external cellular conditions. Moreover, the composition is dynamic and capable of changing in response to different stimuli and cellular signals. Therefore, exosomes are considered one of the most important forms of EVs in intercellular signaling; exosomes play pivotal roles in transmitting bioactive molecules and responding to the everchanging cellular environment. In addition to exosomes, EVs include microvesicles (MVs) and apoptotic bodies. MVs, which are larger than exosomes and range from 100–1000 nm in diameter, result from outward budding and fission of the cell’s plasma membrane. Their cargo predominantly includes cytosolic contents such as proteins, nucleic acids, lipids, and metabolites. However, the absence of specific markers for distinguishing MVs from exosomes remains a challenge3,12. Apoptotic bodies, which make up the largest of the three EV groups, typically measure between 1,000 and 5000 nm. They emerge during apoptosis when cells fragment into smaller units and enveloped by membrane-bound vesicles. These vesicles contain DNA fragments, histones, chromatin remnants, cytosolic fractions, and degraded proteins. Typically, apoptotic bodies are cleared by phagocytic cells7,12. Other types of EVs with potentially specialized functions have also been described. Large oncosomes (1 μm) and ARRDC1-mediated microvesicles (ARMMs) arise from outward protrusions of the plasma membrane that are excised and shed into the extracellular space. Recently, migrasomes derived from retraction fibers have been described and characterized13. Additionally, two nonvesicular extracellular nanoparticles (NVEPs), exomeres and supermeres, have been shown to be enriched in many cargoes previously associated with EVs. In this review, we focused on exosomes, the most studied type of EV. Distinct characteristics of exosomes and the composition of exosomes Exosomes have garnered significant attention due to their unique characteristics that distinguish them from other EVs (Fig. 1). The lipid bilayer membrane surrounding exosomes is composed of phosphatidylserine, phosphatidylcholine, sphingomyelin, ceramides, and cholesterol and plays a crucial role in maintaining exosome structural integrity and function4. Exosomes are rich in various forms of nucleic acids, including mRNAs, miRNAs, ribosomal RNAs (rRNAs), long noncoding RNAs (lncRNAs), transfer RNAs (tRNAs), small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs), and p-element-induced wimpy testes (piwi)-interacting RNAs (piRNAs)14. Exosomes can also include double-stranded or single-stranded DNA (dsDNA and ssDNA, respectively) and mitochondrial DNA (mtDNA)15,16. [Figure: Mechanisms of extracellular vesicle (EV) biogenesis and EV components.EV biogenesis occurs through multiple pathways, including through multivesicular bodies (MVBs) within endosomes, which leads to the secretion of exosomes, and through the plasma membrane, which results in microvesicle (MV) generation. After endocytosis, early endosomes undergo maturation in MVBs, during which they form intraluminal vesicles (ILVs)

Read the complete text